Site access drives cost-effectiveness of TAVR, study finds

11/12/2012 | TCTMD.com

The cost-effectiveness of transcatheter aortic valve replacement in high-risk patients with severe aortic stenosis is access-site dependent, according to an analysis of the PARTNER trial published in the Journal of the American College of Cardiology. The findings support the transfemoral route, which demonstrated similar overall costs to surgery but shorter stays in the ICU and hospital overall and shorter procedural time.

View Full Article in:

TCTMD.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY